Single peptide Vial strength 10 mg
Eloralintide10 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Eloralintide, explained simply
An investigational amylin receptor agonist studied for its relationship with satiety and energy balance.
Research area
Appetite and weight management
How it works
Activates amylin signalling, which is involved in satiety, gastric emptying and glucose regulation.
Why it matters
Clinical research examines its effects on appetite and weight.
What has been observed
Human-study dose data are available; worked vial calculations represent a separate context.
Effects and points to consider
A calculated vial concentration does not establish equivalence with formulations used in clinical studies.
01 / Vial strength 10 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg Eloralintide |
|---|---|
| Final volume | 1 mL |
| Concentration | 10 mg/mL |
| One U-100 unit | 100 mcg in 0.01 mL |
Phase 2 Fixed-Dose Arms Using a 10 mg/mL Worked Preparation
| Research Period | Amount per Administration | U-100 Units (mL) |
|---|---|---|
| 48 weeks | 1 mg | 10 units (0.10 mL) |
| 48 weeks | 3 mg | 30 units (0.30 mL) |
| 48 weeks | 6 mg | 60 units (0.60 mL) |
| 48 weeks | 9 mg | 90 units (0.90 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.